Boston Scientific says a cybersecurity incident has disrupted its global operations, including some information systems used to process and ship customer orders, making it the latest healthcare company to be hit by a cyberattack.

The medical device maker said it detected the incident on Aug. 25 and immediately activated its incident-response procedures. The company is working with third-party cybersecurity specialists to investigate the attack and contain the threat.
The incident is expected to continue affecting parts of Boston Scientific’s business as the company works to restore its systems, it said.
Boston Scientific said it had not determined whether the incident was reasonably likely to have a material impact on its business.
The company said its investigation was ongoing and that the full scope and nature of the incident had not yet been determined.
Shares of Boston Scientific fell 3.5% in premarket trading.
Boston Scientific makes medical devices used in areas including cardiovascular, endoscopy, urology, neuromodulation and other medical specialties. The company operates globally, with manufacturing and distribution facilities across multiple regions.
The disruption to systems used to process and ship customer orders could affect the company’s ability to fulfill some orders while recovery efforts are underway, although Boston Scientific did not provide details on the extent of any delays.
The attack adds to a growing list of cyber incidents affecting healthcare companies, which are frequent targets because of the sector’s reliance on interconnected information systems and the sensitive nature of medical and patient data.
Medical device makers Abbott Laboratories (ABT.N), Stryker (SYK.N) and Medtronic (MDT.N), health insurer Clover Health (CLOV.O), drugmaker Novo Nordisk (NOVOb.CO) and medical equipment supplier West Pharmaceutical Services (WST.N) have also recently reported cyber incidents.
Healthcare companies have increasingly warned that cyberattacks can disrupt not only corporate IT systems but also manufacturing, supply chains, order processing and other business-critical operations.
Boston Scientific did not disclose whether patient or other sensitive data had been accessed or compromised.
The company also did not identify the perpetrators or provide details on the type of cyberattack involved.
Stay ahead of the Stories shaping our world. Subscribe to Impact Newswire and join our
WhatsApp Channel for updates on global tech, business, and innovation—all in one place.
Dive deeper into the future with the Cause Effect 4.0 Podcast, where we explore the ideas, trends, and technologies driving the global AI conversation.
Got a story to share? Contact Us to reach a global audience with Impact Newswire.
Faustine Ngila is the AI Editor at Impact Newswire, based in Nairobi, Kenya. He is an award-winning journalist specializing in artificial intelligence, blockchain, and emerging technologies.
He previously worked as a global technology reporter at Quartz in New York and Digital Frontier in London, where he covered innovation, startups, and the global digital economy.
With years of experience reporting on cutting-edge technologies, Faustine focuses on AI developments, industry trends, and the impact of technology on society.
Discover more from Impact Newswire
Subscribe to get the latest posts sent to your email.



